CFO appointment
Nature's Sunshine Products, Inc. appoints Ruth Perkins as CFO
Nature's Sunshine Products, Inc. reported in a Form 8-K filed August 6, 2026 that Ruth Perkins was appointed Executive Vice President, Chief Financial Officer, effective September 1, 2026.
In the filing's words
On August 4, 2026, the Company’s Board of Directors appointed Ms. Ruth Perkins to serve as the Executive Vice President, Chief Financial Officer, effective September 1, 2026.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Nature's Sunshine Products, Inc. (NATR) |
|---|---|
| Event | Appointment |
| Incoming | Ruth Perkins |
| Title in the filing | Executive Vice President, Chief Financial Officer |
| Effective | September 1, 2026 |
| 8-K filed | August 6, 2026 |
| Internal promotion | No |
| Prior role (per filing) | Senior Vice President, Global Value Chain Finance, The Estée Lauder Companies Inc. |
| SEC CIK | 0000275053 |
Nature's Sunshine Products, Inc. reported this change in a Form 8-K, Item 5.02, filed August 6, 2026. The filing's own words are quoted above.
Same industry, August 2026
4Other moves filed that month at companies the roster files under SIC “Pharmaceutical Preparations”.
2 months ago· 2026-08-19DeparturePDSB
PDS Biotechnology Corporation discloses CFO departure: Lars Boesgaard
3 months ago· 2026-08-13DepartureADIL
Adial Pharmaceuticals, Inc. discloses CFO departure: Vinay Shah
3 months ago· 2026-08-13AppointmentOLMA
Olema Pharmaceuticals, Inc. appoints Jason O'Byrne as CFO
3 months ago· 2026-08-03AppointmentCUE
Cue Biopharma, Inc. appoints James Ahlers as CFO
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Ruth Perkins? Send a correction with the primary source.